{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:24:05Z","timestamp":1783085045598,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/12165-8"],"award-info":[{"award-number":["2020\/12165-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/12165-8"],"award-info":[{"award-number":["2020\/12165-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["IEC\\NSFC\\201116"],"award-info":[{"award-number":["IEC\\NSFC\\201116"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBF007\\100054"],"award-info":[{"award-number":["SBF007\\100054"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70064-8","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:02:12Z","timestamp":1724796132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I\/II randomized and triple-blind clinical trial"],"prefix":"10.1038","volume":"14","author":[{"given":"Vinicius Tadeu","family":"Ramos da Silva Grillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus","family":"Bertanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenize","family":"da Silva Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Andrade","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Luciano","family":"Mellucci Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rahal Guaragna Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson Luiz","family":"Durigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia","family":"Dias Sertorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"de Assis Golim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline M\u00e1rcia","family":"Marques Braz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Naz\u00e1rio","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Bonciani Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Constantino","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Rodrigues Guzzo Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio","family":"Floren\u00e7a Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Jos\u00e9","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Caputo Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejane Maria","family":"Tommasini Grotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"de C\u00e1ssia Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas","family":"de Moura Campos Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcone","family":"Lima Sobreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Alessandra Pellison Nunes","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Naime Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Magno Castelo Branco","family":"Fortaleza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"70064_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12931-020-01462-5","volume":"21","author":"S Dhont","year":"2020","unstructured":"Dhont, S., Derom, E., Van Braeckel, E., Depuydt, P. & Lambrecht, B. N. The pathophysiology of \u2018happy\u2019 hypoxemia in COVID-19. Respir. Res. 21, 198 (2020).","journal-title":"Respir. Res."},{"key":"70064_CR2","unstructured":"Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S. C. & Di Napoli, R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls (2024)."},{"key":"70064_CR3","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.xphs.2022.06.004","volume":"111","author":"G Sahin","year":"2022","unstructured":"Sahin, G. et al. Antivirals and the potential benefits of orally inhaled drug administration in COVID-19 treatment. J. Pharm. Sci. 111, 2652\u20132661 (2022).","journal-title":"J. Pharm. Sci."},{"key":"70064_CR4","doi-asserted-by":"crossref","unstructured":"Conzelmann, C. et al. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19. Clin. Med. (Northfield. Il). 20, e218\u2013e221 (2020).","DOI":"10.7861\/clinmed.2020-0351"},{"key":"70064_CR5","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1055\/s-0040-1721319","volume":"120","author":"CJ Mycroft-West","year":"2020","unstructured":"Mycroft-West, C. J. et al. Heparin inhibits cellular invasion by SARS-CoV-2: Structural dependence of the interaction of the spike S1 receptor-binding domain with heparin. Thromb. Haemost. 120, 1700\u20131715 (2020).","journal-title":"Thromb. Haemost."},{"key":"70064_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jim-2021-001951","volume":"69","author":"X Yu","year":"2021","unstructured":"Yu, X. Another new application of heparin in Covid-19: More than anticoagulation and antiviral. J. Investig. Med. 69, 1258\u20131258 (2021).","journal-title":"J. Investig. Med."},{"key":"70064_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101507","volume":"298","author":"G Paiardi","year":"2022","unstructured":"Paiardi, G. et al. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms. J. Biol. Chem. 298, 101507 (2022).","journal-title":"J. Biol. Chem."},{"key":"70064_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M. et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183, 1043-1057.e15 (2020).","journal-title":"Cell"},{"key":"70064_CR9","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3390\/jcm11113099","volume":"11","author":"M Mangiafico","year":"2022","unstructured":"Mangiafico, M., Caff, A. & Costanzo, L. The role of heparin in COVID-19: An update after two years of pandemics. J. Clin. Med. 11, 3099 (2022).","journal-title":"J. Clin. Med."},{"key":"70064_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.120595","volume":"267","author":"J Li","year":"2022","unstructured":"Li, J., Zhang, Y., Pang, H. & Li, S. J. Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 267, 120595 (2022).","journal-title":"Spectrochim. Acta. A. Mol. Biomol. Spectrosc."},{"key":"70064_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/bph.15304","volume":"178","author":"JA Tree","year":"2021","unstructured":"Tree, J. A. et al. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br. J. Pharmacol. 178, 626\u2013635 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"70064_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104873","volume":"181","author":"SY Kim","year":"2020","unstructured":"Kim, S. Y. et al. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions. Antiviral Res. 181, 104873 (2020).","journal-title":"Antiviral Res."},{"key":"70064_CR13","doi-asserted-by":"crossref","unstructured":"Bertanha, M. et al. Nebulized enriched heparin to treat no critical patients with Sars-Cov-2. Medicine (Baltimore). 100, e28288 (2021).","DOI":"10.1097\/MD.0000000000028288"},{"key":"70064_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S2213-2600(20)30470-7","volume":"9","author":"B Dixon","year":"2021","unstructured":"Dixon, B. et al. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir. Med. 9, 360\u2013372 (2021).","journal-title":"Lancet Respir. Med."},{"key":"70064_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1124\/pr.115.011247","volume":"68","author":"B Mulloy","year":"2016","unstructured":"Mulloy, B., Hogwood, J., Gray, E., Lever, R. & Page, C. P. Pharmacology of Heparin and Related Drugs. Pharmacol. Rev. 68, 76\u2013141 (2016).","journal-title":"Pharmacol. Rev."},{"key":"70064_CR16","unstructured":"Institute, N. C. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. (2017)."},{"key":"70064_CR17","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1111\/bcp.15253","volume":"88","author":"FMP van Haren","year":"2022","unstructured":"van Haren, F. M. P. et al. Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective ra. Br. J. Clin. Pharmacol. 88, 3272\u20133287 (2022).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"70064_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-017-0572-3","volume":"18","author":"M Camprub\u00ed-Rimblas","year":"2017","unstructured":"Camprub\u00ed-Rimblas, M. et al. Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury. Respir. Res. 18, 89 (2017).","journal-title":"Respir. Res."},{"key":"70064_CR19","doi-asserted-by":"crossref","unstructured":"Lan, X. et al. Nebulized heparin for inhalation injury in burn patients: a systematic review and meta-analysis. Burn. Trauma 8, (2020).","DOI":"10.1093\/burnst\/tkaa015"},{"key":"70064_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/8755122520925774","volume":"36","author":"MK Phelps","year":"2020","unstructured":"Phelps, M. K., Olson, L. M., Patel, M. A. V. B., Thompson, M. J. & Murphy, C. V. Nebulized heparin for adult patients with smoke inhalation injury: A review of the literature. J. Pharm. Technol. 36, 130\u2013140 (2020).","journal-title":"J. Pharm. Technol."},{"key":"70064_CR21","doi-asserted-by":"crossref","unstructured":"Abdelaal Ahmed Mahmoud, A., Mahmoud, H. E., Mahran, M. A. & Khaled, M. Streptokinase Versus Unfractionated Heparin Nebulization in Patients With Severe Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial With Observational Controls. J. Cardiothorac. Vasc. Anesth. 34, 436\u2013443 (2020).","DOI":"10.1053\/j.jvca.2019.05.035"},{"key":"70064_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.15585\/mmwr.mm6924e2","volume":"69","author":"EK Stokes","year":"2020","unstructured":"Stokes, E. K. et al. Coronavirus disease 2019 case surveillance\u2014united states, January 22\u2013May 30, 2020. MMWR. Morb. Mortal. Wkly. Rep. 69, 759\u2013765 (2020).","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"70064_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5557582","volume":"2021","author":"M Sadeghi-Haddad-Zavareh","year":"2021","unstructured":"Sadeghi-Haddad-Zavareh, M. et al. C-reactive protein as a prognostic indicator in COVID-19 patients. Interdiscip. Perspect. Infect. Dis. 2021, 1\u20135 (2021).","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"70064_CR24","doi-asserted-by":"crossref","unstructured":"WONG, C. K. et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136, 95\u2013103 (2004).","DOI":"10.1111\/j.1365-2249.2004.02415.x"},{"key":"70064_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","volume":"104","author":"WH Mahallawi","year":"2018","unstructured":"Mahallawi, W. H., Khabour, O. F., Zhang, Q., Makhdoum, H. M. & Suliman, B. A. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 104, 8\u201313 (2018).","journal-title":"Cytokine"},{"key":"70064_CR26","doi-asserted-by":"publisher","first-page":"2201514","DOI":"10.1183\/13993003.01514-2022","volume":"61","author":"F Salton","year":"2023","unstructured":"Salton, F. et al. Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS). Eur. Respir. J. 61, 2201514 (2023).","journal-title":"Eur. Respir. J."},{"key":"70064_CR27","doi-asserted-by":"publisher","first-page":"2200025","DOI":"10.1183\/13993003.00025-2022","volume":"60","author":"C Salvarani","year":"2022","unstructured":"Salvarani, C. et al. Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial. Eur. Respir. J. 60, 2200025 (2022).","journal-title":"Eur. Respir. J."},{"key":"70064_CR28","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/v15102101","volume":"15","author":"A Libra","year":"2023","unstructured":"Libra, A. et al. Use of remdesivir in patients hospitalized for COVID-19 pneumonia: Effect on the hypoxic and inflammatory state. Viruses 15, 2101 (2023).","journal-title":"Viruses"},{"key":"70064_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","volume":"28","author":"FL van de Veerdonk","year":"2022","unstructured":"van de Veerdonk, F. L. et al. A guide to immunotherapy for COVID-19. Nat. Med. 28, 39\u201350 (2022).","journal-title":"Nat. Med."},{"key":"70064_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S2213-2600(20)30513-0","volume":"9","author":"L Ball","year":"2021","unstructured":"Ball, L., Schultz, M. J. & Pelosi, P. Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia. Lancet Respir. Med. 9, 321\u2013322 (2021).","journal-title":"Lancet Respir. Med."},{"key":"70064_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2023.102212","volume":"80","author":"G DeNucci","year":"2023","unstructured":"DeNucci, G. et al. Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study. Pulm. Pharmacol. Ther. 80, 102212 (2023).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"70064_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/jth.14685","volume":"18","author":"M Camprub\u00ed-Rimblas","year":"2020","unstructured":"Camprub\u00ed-Rimblas, M. et al. Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats. J. Thromb. Haemost. 18, 571\u2013583 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"70064_CR33","doi-asserted-by":"publisher","first-page":"1016402","DOI":"10.3389\/fpubh.2022.1016402","volume":"10","author":"SA Costa Clemens","year":"2022","unstructured":"Costa Clemens, S. A. et al. Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP. Front. public Heal. 10, 1016402 (2022).","journal-title":"Front. public Heal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70064-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:08:44Z","timestamp":1724796524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70064-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70064"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70064-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"23 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19902"}}